PD-1 and PD-L2 expression predict relapse risk and poor survival in patients with stage III colorectal cancer


Zengin M., Zergeroglu S., Okcu O., Benek S.

CELLULAR ONCOLOGY, vol.44, no.2, pp.423-432, 2021 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 44 Issue: 2
  • Publication Date: 2021
  • Doi Number: 10.1007/s13402-020-00579-5
  • Title of Journal : CELLULAR ONCOLOGY
  • Page Numbers: pp.423-432

Abstract

Background Immune responses have long been an area of interest in cancer research. In this study, the effects of programmed cell death-1 (PD-1) and its ligand (PD-L2) on the prognosis of colorectal cancer (CRC) were investigated.